3+ day, 58+ min ago   (545+ words) There's been a lot of talk about forging closer ties between Europe and Canada in response to the US' aggressive disruption of international trade. Now, two senior figures in Canada's life sciences sector have said they see scope for greater…...

3+ day, 2+ hour ago   (562+ words) Bayer has won FDA approval for oral HER2 inhibitor Hyrnuo as a first-line treatment for advanced HER2-mutant non-small cell lung cancer (NSCLC), just a year after it was cleared as a second-line option. Hyrnuo (sevabertinib) has been cleared for earlier use…...

3+ day, 4+ hour ago   (403+ words) Pharmaceutical firms are making an expensive mistake. They develop a drug, see it through clinical trials, and only then pause to ask whether it will secure reimbursement. But by then, capital has already been committed, and the drug has already…...

4+ day, 4+ hour ago   (267+ words) Dame Kate Bingham completes the confirmed line-up. Best known for chairing the UK's Vaccine Taskforce during the COVID-19 pandemic, she brings a venture capital and drug development perspective on what it takes to move quickly from science to approved product…...

5+ day, 13+ min ago   (552+ words) Swiss biotech Pharvaris has reported positive data from a phase 3 trial of its drug for hereditary angioedema (HAE), setting up marketing applications next year. The drug – an extended-release formulation of bradykinin B2 receptor antagonist deucrictibant – achieved an 83% reduction compared to placebo…...

5+ day, 23+ hour ago   (159+ words) The 10th Dermatology Drug Development Summit returns in 2026 as the leading premier forum dedicated to advancing the discovery, development, and commercialization of innovative therapies for inflammatory skin disease. The meeting provides a unique opportunity to benchmark emerging science, evaluate novel targets,…...

6+ day, 3+ hour ago   (526+ words) The FDA has gone against the advice of its own expert advisors and approved AstraZeneca's Etcamah as a frontline treatment for breast cancer. Oral selective oestrogen receptor degrader (SERD) Etcamah (camizestrant) has been cleared in the US for use in…...

6+ day, 4+ hour ago   (536+ words) An NHS trust in the UK has become the first site in Europe to offer Roche's experimental drug trontinemab to patients enrolled in a large-scale trial to see if it can delay or prevent Alzheimer's disease. The phase 3 PrevenTRON study…...

1+ week, 4+ day ago   (496+ words) PMV Pharma is preparing to file for approval of its oral p53 protein reactivator drug rezatopopt in the first quarter of 2027, after reporting positive results in a phase 2 trial in ovarian cancer. That schedule means Princeton, New Jersey-based PMV has a…...

1+ week, 4+ day ago   (539+ words) The US Advanced Research Projects Agency for Health (ARPA-H) has awarded $125 million in funding, split across five groups, to build a network for producing 'made-to-order' RNA-based genetic medicines. The Genetic Medicines and Individualised Manufacturing for Everyone (GIVE) programme will replace…...